Please login to the form below

Not currently logged in
Email:
Password:

charity

This page shows the latest charity news and features for those working in and with pharma, biotech and healthcare.

NICE lung cancer backing for Keytruda is biggest expansion yet

NICE lung cancer backing for Keytruda is biggest expansion yet

NHS. Prof Charles Swanton. Medical charity Cancer Research UK (CRUK) also welcomed the news.

Latest news

More from news
Approximately 19 fully matching, plus 532 partially matching documents found.

Latest Intelligence

  • Comment: the new UK pricing deal – welcome news, but lessons to be learned Comment: the new UK pricing deal – welcome news, but lessons to be learned

    Unless we work constructively with parliamentarians, policymakers and charities to persuade them that there are genuine problems that need to be solved, these reviews will simply conclude that the existing systems

  • What can pharma learn from the charity sector? What can pharma learn from the charity sector?

    the charity sector (or third sector, as it’s also known) to better support its patients. ... Create partnerships. Within the community of health charity supporters, there is often scepticism about the intentions of pharmaceutical companies.

  • Is flexible working the future?

    A survey released in January by the charity Working Families, found that fewer than half of those questioned (44%) felt that flexible working was a genuine option in their place of

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    The company is still in the early stages of proving its technology, and recently signed a deal to work with a group of charities for the blind aimed at discovering new

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    28. Baroness Delyth Morgan, Breast Cancer Now Chief Executive. Delyth has been a central figure in breast cancer charities for more than 20 years, building the sector’s voice in health ... In 2015 she oversaw the merger of her organisation Breast

More from intelligence
Approximately 1 fully matching, plus 46 partially matching documents found.

Latest appointments

  • Healthcare Comms appointments Healthcare Comms appointments

    For the past five years, Guldbrandsen has headed Macmillan’s innovation and strategic partnerships team and before that she was head of design strategy at the Design Council, an independent charity. ... Her oncology and charity background adds even

  • Healthcare comms appointments Healthcare comms appointments

    Over the last 20 years, Patel has led digital, content and social media strategies for a variety of organisations in they health, charity and education sectors.

  • New appointments at 90TEN and WA Health New appointments at 90TEN and WA Health

    Having started her career as a campaigner in charities including Mencap and Mind, Caroline worked as a political adviser to a government minister and local council leaders.

  • Adelphi Research UK strengthens its offerings Adelphi Research UK strengthens its offerings

    He joins the group from Harris Interactive, bringing 15 years’ experience in quantitative and qualitative research from a variety of industries, including public sector, charity and education.

  • Picker appoints new CEO Picker appoints new CEO

    Chris Graham to focus on person-centred care. International charity Picker has appointed Chris Graham as its new CEO in a role that will see him focus on leading and promoting ... We wish him every success in his new role and on behalf of the board, look

More from appointments
Approximately 1 fully matching, plus 30 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 20 fully matching, plus 93 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics